13
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Electrophoretic Analysis of Serum and Urinary Proteins in Rats with Aminonucleoside-Induced Nephrotic Syndrome

, , &
Pages 149-155 | Published online: 07 Jul 2009

References

  • Bernard DB. Metabolic abnormalities in nephrotic syndrome: Pathophysiology and complications. The nephrotic syndrome. Contemporary issues in nephrol-ogy, B.M Brenner, JH Stein. Churchill Livingstone, New York 1982; 9: 85–119
  • Pedraza-Chaverri J., Cruz C., Ibarra-Rubio M. E., et al. Pathophysiology of experimental nephrotic syndrome induced by puromy-cin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia and renin-angiotensin-aldosterone system on sodium retention. Rev Invest Clin 1990; 42: 29–38
  • Pedraza-Chaverri J., Cruz C., Chávez M. T., et al. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensino-gen and aldosterone. Rev Invest Clin 1990; 42: 120–126
  • Pedraza-Chaverri J., Cruz C., Chávez M. T., Ibarra-Rubio M. E., Tapia E., Peña J. C. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention. Rev Invest Clin 1990; 42: 210–216
  • Lewandowski A. E., Liao WSL, Stinson-Fisher C. A., Kent J. D., Jefferson LS. Effects of experimentally induced nephrosis on protein synthesis in rat liver. Am J Physiol 1988; 254: C634–C642
  • Bernard DB. Extrarenal complications of the nephrotic syndrome. Kidney Int 1988; 33: 1184–1202
  • Beaman M., Oldfield S., Maclennan ICM, Michael J., Adu D. Hypogammaglobulinaemia in nephrotic rats is attributable to hypercatabolism of IgG. Clin Exp Immunol 1988; 74: 425–430
  • Housley J., Jones L., Harvey A. Serum a-macroglobulins in rat aminonucleoside nephrosis. Clin Chim Acta 1968; 21: 85–90
  • Ibarra-Rubio M. E., Cruz C., Tapia E., Peña J. C., Pedraza-Chaverri J. Serum angiotensin converting enzyme activity and plasma renin activity in experimental models of rats. Clin Exp Pharmacol Physiol 1990; 17: 391–399
  • Arévalo A. E., Ibarra-Rubio M. E., Cruz C., Peña J. C., Pedraza-Chaverri J. Angiotensin-I-converting enzyme activity in puromycin aminonucleoside-nephrotic syndrome. Clin Chim Acta 1990; 191: 175–184
  • Girot R., Jaubert F., Leon M., et al. Albumin, fibrinogen, pro-thrombin and antithrombin III variations in blood, urines and liver in rat nephrotic syndrome (Heymann nephritis). Tromb Haemostas 1983; 49: 13–17
  • Marsh NA. The fibrinolytic enzyme system of the rat: The effect of aminonucleoside-induced nephrotic syndrome. Br J Exp Pathol 1969; 50: 1–12
  • Levy E., Ziv E., Bar-On H., Sahfrir E. Chylomicron synthesis in experimental nephrotic syndrome. Biochim Biophys Acta 1989; 1005: 20–26
  • Gherardi E., Calandra S. Plasma and urinary lipids and lipopro-teins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside. Biochim Biophys Acta 1981; 710: 188–196
  • Pedraza-Chaverri J., Cruz C., Tapia E., Peña JC. Activity of serum enzymes in puromycin aminonucleoside-induced nephrotic syndrome. Renal Failure 1992; 14: 523–532
  • Davis R. W., Staprans I., Hutchison F. N., Kaysen GA. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat. J Clin Invest 1990; 86: 600–605
  • Alfrey A. C., Hammond WS. Renal iron handling in the nephrotic syndrome. Kidney Int 1990; 37: 1409–1413
  • Chan Y-L, Mason R. S., Parmentier M., Savdie E., Lissner D., Posemn S. Vitamin D metabolism in nephrotic rats. Kidney Int 1983; 24: 336–341
  • Khamiseh G., Vaziri N. D., Oveisi F., Ahmadnia M. R., Ahmadnia L. Vitamin D absorption, plasma concentration and urinary excretion of 25-hydroxyvitamin D in nephrotic syndrome. Proc Soc Exp Biol Med 1991; 196: 210–213
  • Mainero A., Cruz C., Pedraza-Chaverri J. Serum and urinary cer-uloplasmin in experimental nephrotic syndrome. Clin Invest Med 1992; 15: 295–300
  • Longsworth L. G., Maclnnes DA. An electrophoretic study of nephrotic sera and urine. J Exp Med 1940; 71: 77–82
  • Jensen H. Plasma protein and lipid pattern in the nephrotic syndrome. Acta Med Scand 1967; 182: 465–473
  • Marsh J. B., Sparks CE. Lipoprotein in experimental nephrosis: Plasma levels and composition. Metabolism 1979; 28: 1040–1045
  • Hoch-Ligeti C. Sequence of tissue, serum and urine changes in rats treated with aminonucleoside. Br J Exp Pathol 1960; 41: 119–129
  • Kushner I. The acute phase response: An overview. Methods En-zymol 1988; 163: 373–383
  • Weimer H. E., Benjamin DC. Immunochemical detection of an acute-phase protein in rat serum. Am J Physiol 1965; 209: 736–744
  • Lowry O. A., Rosenbrought N. J., Farr A. L., Randall RJ. Protein measurements with the Folin phenol reagent. J Biol Chem 1951; 193: 265–272
  • Zar JH. Biostatistical Analysis (2nd ed). Prentice-Hall, New York 1984
  • Pedraza-Chaverri J., Huberman A. Actinomycin D blocks the hepatic functional albumin-mRNA increase in aminonucleoside-nephrotic rats. Nephron 1991; 59: 648–650
  • Pedraza-Chaverri J., Cruz C., Ibarra-Rubio M. E., Hernandez C., Tapia E., Peña JC. Urinary excretion of renin and angiotensino-gen in nephrotic rats. Nephron 1991; 57: 106–108
  • Pedraza-Chaverri J., Cruz C., Sandoval A. A., Tapia E., Pena JC. Effect of captopril on urinary excretion of renin and angiotensino-gen in aminonucleoside nephrosis. Renal Failure 1992; 14: 155–159
  • Farqhuar M. G., Palade GE. Glomerular permeability. II. Ferritin transfer across the glomerular capillary wall in nephrotic rats. J Exp Med 1961; 114: 699–741
  • Venkatachalam M. A., Cotran R. S., Karnovsky MJ. An ultrastruc-tural study on glomerular permeability in aminonucleoside nephrosis using catalase as tracer protein. J Exp Med 1970; 142: 1168–1180
  • Steines W. J., Mehl JW. The elevation of α2-macroglobulin and trypsin-binding activity in nephrosis. J Lab Clin Med 1966; 67: 559–565

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.